Clinical Trial

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine whether a nutrition and exercise program can improve pathologic complete response (pCR) in women with triple-negative breast cancer (TNBC) receiving chemo-immunotherapy before surgery. Pathologic complete (pCR) response means that no cancer in the breast is seen after chemotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-03; most recent amendment 2025-10-27.
Status change: Not Yet Recruiting → Recruiting 2025-10-27
Trial Details
NCT Number NCT07066189
Lead Sponsor Yale University
Collaborators: Breast Cancer Research Foundation
Conditions Triple Negative Breast Cancer
Enrollment 160 participants
Start Date 2025-10-17
Primary Completion 2029-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2025-10-29